Frog skin cultures secrete anti-yellow fever compounds

J Antibiot (Tokyo). 2016 Nov;69(11):783-790. doi: 10.1038/ja.2016.16. Epub 2016 Apr 6.

Abstract

There is an urgent need to develop novel antimicrobial substances. Antimicrobial peptides (AMPs) are considered as promising candidates for future therapeutic use. Because of the re-emergence of the Flavivirus infection, and particularly the yellow fever virus (YFV), we have compared the antiviral activities from skin secretions of seven different frog species against YFV (strain 17D). Secretions from Sphaenorhynchus lacteus, Cryptobatrachus boulongeri and Leptodactylus fuscus displayed the more powerful activities. S. lacteus was found to inhibit viral lysis of Vero E6 cells even at the highest viral concentration evaluated of 10 LD50. We also report the identification of a novel frenatin-related peptide from S. lacteus and found that this peptide-on its own-can lead to 35% protection against YVF, while displaying no cytotoxicity against somatic cells even at fivefold higher concentrations. These results are attractive and support the need for continued exploration of new sources of AMPs from frog skin secretions such as those described here in the development of new compounds for the treatment of infectious diseases in general and specific viral infections in particular.

MeSH terms

  • Amino Acid Sequence
  • Amphibian Proteins / pharmacology*
  • Animals
  • Antiviral Agents / pharmacology*
  • Base Sequence
  • CHO Cells
  • Chlorocebus aethiops
  • Cloning, Molecular
  • Cricetulus
  • Peptides / pharmacology
  • Ranidae / classification*
  • Sequence Analysis, DNA
  • Skin / chemistry*
  • Vero Cells
  • Yellow fever virus / drug effects*

Substances

  • Amphibian Proteins
  • Antiviral Agents
  • Peptides